Rothschild & Co Redburn analyst Issie Kirby upgraded Sonova (SONVY) to Neutral from Sell with a price target of CHF 215, up from CHF 210. The firm says the weaker hearing aid market outlook and heightened competitive landscape are now priced into the shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SONVY: